Nephrology and Hypertension

Nephrology and Hypertension Publications

  1. Akimova T, Kamath BM, Goebel JW, Meyers KE, Rand EB, Hawkins A, Levine MH, Bucuvalas JC, Hancock WW. Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. Am J Transplant. 2012; 12:3449-61.
  2. Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ. Continuous renal replacement therapy for children <10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr. 2013; 162:587-592 e3.
  3. Basu RK, Chawla LS, Wheeler DS, Goldstein SL. Renal angina: an emerging paradigm to identify children at risk for acute kidney injury. Pediatr Nephrol. 2012; 27:1067-78.
  4. Bennett MR. Biomarkers of therapeutic response in primary nephrotic syndrome: response. Pediatr Nephrol. 2013; 28:161-2.
  5. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013; 381:817-24.
  6. Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, White CT, Furth S, Warady BA, Mitsnefes M. Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol. 2012; 7:1930-7.
  7. Bridges BC, Askenazi DJ, Smith J, Goldstein SL. Pediatric renal replacement therapy in the intensive care unit. Blood Purif. 2012; 34:138-48.
  8. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012; 64:2687-97.
  9. Claes DJ, Jackson E. Cystinuria: mechanisms and management. Pediatr Nephrol. 2012; 27:2031-8.
  10. Cruz DN, Gaiao S, Maisel A, Ronco C, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review. Clin Chem Lab Med. 2012; 50:1533-45.
  11. Dawoud D, Lyndon W, Mrug S, Bissler JJ, Mrug M. Impact of ultrasound-guided kidney biopsy simulation on trainee confidence and biopsy outcomes. Am J Nephrol. 2012; 36:570-4.
  12. Devarajan P. Biomarkers for Assessment of Renal Function During Acute Kidney Injury. In: RJ Alpern, SC Herbert, DW Seldin, GH Giebisch, eds. Seldin and Giebisch's the kidney: physiology & pathophysiology. Amsterdam; Boston: Elsevier Academic Press; 2013:2513-2526.
  13. Devarajan P. Biomarkers of Acute Kidney Injury. In: B Jacobs, M Rigby, eds. Current Concepts In Pediatric Critical Care. Mount Prospect, IL: Society of Critical Care Medicine; 2013:77-88.
  14. Devarajan P. Pediatric Acute Kidney Injury: Different From Acute Renal Failure But How And Why. Curr Pediatr Rep. 2013; 1:34-40.
  15. Devarajan P. (2012) Prevention and management of acute kidney injury (acute renal failure) in children. UpToDate. Watham, MA, UpToDate. .
  16. Devarajan P, Arnold WC. (Nov 29, 2012) Myoglobinuria. Medscape. Medscape. .
  17. Devarajan P, Barasch JM. (2012) Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker for Acute Kidney Injury. Recent Patents on Biomarkers. 2:179-189.
  18. Fleming GM, Walters S, Goldstein SL, Alexander SR, Baum MA, Blowey DL, Bunchman TE, Chua AN, Fletcher SA, Flores FX, Fortenberry JD, Hackbarth R, McBryde K, Somers MJ, Symons JM, Brophy PD. Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Pediatr Crit Care Med. 2012; 13:e299-304.
  19. Fukuda T, Goebel J, Cox S, Maseck D, Zhang K, Sherbotie JR, Ellis EN, James LP, Ward RM, Vinks AA. UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients. Ther Drug Monit. 2012; 34:671-9.
  20. Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes. 2013; 11:30.
  21. Goebel J, Laskin B. Should recipients with obstructive uropathy undergo close surveillance for BK virus infection post-transplant?. Pediatr Transplant. 2012; 16:697-8.
  22. Goldstein SL, Morris D, Warady BA. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Am J Kidney Dis. 2013; 61:588-97.
  23. Hooper D. (2012) Kidney Transplantation – Quality Measures webpage. Cincinnati Children’s Hospital Medical Center. July 11, 2013:.
  24. Hooper DK, Kirby CL, Margolis PA, Goebel J. Reliable individualized monitoring improves cholesterol control in kidney transplant recipients. Pediatrics. 2013; 131:e1271-9.
  25. Hooper DK, Williams JC, Carle AC, Amaral S, Chand DH, Ferris ME, Patel HP, Licht C, Barletta GM, Zitterman V, Mitsnefes M, Patel UD. The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2013; 28:939-49.
  26. Howard AD, Howard RS, Goldstein SL, Meyer KB. Fistula First Breakthrough Initiative (FFBI): lessons about arteriovenous fistula prevalence goals. Am J Kidney Dis. 2013; 61:523-5.
  27. Jayakumar C, Ranganathan P, Devarajan P, Krawczeski CD, Looney S, Ramesh G. Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury. PLoS One. 2013; 8:e58446.
  28. Jefferies JL, Goldstein SL. Cardiorenal [corrected] syndrome: an emerging problem in pediatric critical care. Pediatr Nephrol. 2013; 28:855-62.
  29. Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, Davies SM. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?. Transfusion. 2013; 53:661-7.
  30. Koyner JL, Garg AX, Shlipak MG, Patel UD, Sint K, Hong K, Devarajan P, Edelstein CL, Zappitelli M, Thiessen-Philbrook H, Parikh CR. Urinary cystatin C and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2013; 61:730-8.
  31. Laskin BL, Goebel J, Starke JR, Schauer DP, Eckman MH. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children. Am J Kidney Dis. 2013; 61:22-32.
  32. Laskin BL, Nehus E, Goebel J, Khoury JC, Davies SM, Jodele S. Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012; 18:1745-52.
  33. Malatesta-Muncher R, Wansapura J, Taylor M, Lindquist D, Hor K, Mitsnefes M. Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant. Pediatr Nephrol. 2012; 27:1157-64.
  34. Miller ER 3rd, Juraschek SP, Anderson CA, Guallar E, Henoch-Ryugo K, Charleston J, Turban S, Bennett MR, Appel LJ. The Effects of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation on Biomarkers of Kidney Injury in Adults With Diabetes: Results of the GO-FISH trial. Diabetes Care. 2013; 36:1462-9.
  35. Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA. 2013; 309:1921-9.
  36. Nehus E, Furth S, Warady B, Mitsnefes M. Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. J Pediatr. 2012; 161:276-80.
  37. Nehus E, Goebel J, Abraham E. Outcomes of steroid-avoidance protocols in pediatric kidney transplant recipients. Am J Transplant. 2012; 12:3441-8.
  38. Nehus EJ, Laskin BL, Kathman TI, Bissler JJ. Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr Nephrol. 2013; 28:453-61.
  39. Neul SK, Minard CG, Currier H, Goldstein SL. Health-related quality of life functioning over a 2-year period in children with end-stage renal disease. Pediatr Nephrol. 2013; 28:285-93.
  40. Nickolas TL, Forster CS, Sise ME, Barasch N, Valle DS, Viltard M, Buchen C, Kupferman S, Carnevali ML, Bennett M, Mattei S, Bovino A, Argentiero L, Magnano A, Devarajan P, Mori K, Erdjument-Bromage H, Tempst P, Allegri L, Barasch J. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int. 2012; 82:718-22.
  41. O'Brien K, Leach J, Jones B, Bissler J, Zuccarello M, Abruzzo T. Calcifications associated with pediatric intracranial arterial aneurysms: incidence and correlation with pathogenetic subtypes. Childs Nerv Syst. 2013; 29:643-9.
  42. Paragas N, Qiu A, Hollmen M, Nickolas TL, Devarajan P, Barasch J. NGAL-Siderocalin in kidney disease. Biochim Biophys Acta. 2012; 1823:1451-8.
  43. Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M, Devarajan P, Venkatachalam MA. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol. 2013; 24:506-17.
  44. Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA, Furth S. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension. 2012; 60:43-50.
  45. Shlipak MG, Scherzer R, Abraham A, Tien PC, Grunfeld C, Peralta CA, Devarajan P, Bennett M, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Sarnak MJ, Parikh CR. Urinary markers of kidney injury and kidney function decline in HIV-infected women. J Acquir Immune Defic Syndr. 2012; 61:565-73.
  46. Siroky BJ, Yin H, Babcock JT, Lu L, Hellmann AR, Dixon BP, Quilliam LA, Bissler JJ. Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress. Am J Physiol Renal Physiol. 2012; 303:F831-44.
  47. Sirota JC, Walcher A, Faubel S, Jani A, McFann K, Devarajan P, Davis CL, Edelstein CL. Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation. BMC Nephrol. 2013; 14:17.
  48. Srivaths PR, Sutherland S, Alexander S, Goldstein SL. Two-point normalized protein catabolic rate overestimates nPCR in pediatric hemodialysis patients. Pediatr Nephrol. 2013; 28:797-801.
  49. Zappitelli M, Coca SG, Garg AX, Krawczeski CD, Thiessen Heather P, Sint K, Li S, Parikh CR, Devarajan P. The association of albumin/creatinine ratio with postoperative AKI in children undergoing cardiac surgery. Clin J Am Soc Nephrol. 2012; 7:1761-9.